CytoDyn has already completed a Phase 2 and Phase 3 trial for mild-to-moderate and severe-to-critical COVID-19 patients, respectively, for which CytoDyn did not meet its primary or secondary endpoints, except for the secondary endpoint in the critically ill subpopulation. More information is at www.cytodyn.com. https://www.sec.gov/Archives/edgar/data/0001175680/000119312521298898/d164303dex991.htm
The above says- More information is at www.cytodyn.com.
Where is that info located on cytodyn.com with link included please?
Last I checked, CYDY DELETED that info from their website...did it re-appear yet?